Senores Pharmaceuticals Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Senores Pharmaceuticals Limited
Symbol
SENORES
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Additional Disclosure Date
29-Apr-2026
Additional Disclosure Designation
CFO
Additional Disclosure Name Of Signatory
DEVAL RAJNIKANT SHAH
Additional Disclosure Place
AHMEDABAD
Advertisements As Per Regulation471
Yes
Affirmations
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company.
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Yes
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Board Composition
Yes
Code Of Conduct
Yes
Company Remarks
During the half year, no loans,guarantees, comfort letters or securities in connection with any loans is given by the company.
Compliance Certificate
Yes
Compliance Status
No
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Not Applicable
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
29-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://senorespharma.com/reports1/
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://senorespharma.com/investor-meet/
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://senorespharma.com/announcements/
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://senorespharma.com/policies/
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://senorespharma.com/policies/
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://senorespharma.com/financials/
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://senorespharma.com/about-us/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://senorespharma.com/policies/
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://senorespharma.com/financials/
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://senorespharma.com/policies/
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://senorespharma.com/policies/
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://senorespharma.com/shareholding/
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://senorespharma.com/reg-46-of-sebi-lodr-regulations/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://senorespharma.com/reg-46-of-sebi-lodr-regulations/
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://senorespharma.com/investor-grievance/
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://senorespharma.com/announcements/
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://senorespharma.com/moa-aoa/
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://senorespharma.com/announcements/ https://senorespharma.com/investor-meet/
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://senorespharma.com/reports1/
Disclosure Web Link Of Statements Of Deviations Or Variations As Specified In Regulation32Is Placed
https://senorespharma.com/announcements/
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE0RB801010
Market Capitalisation As Per Immediate Previous Financial Year
Top 1000 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Vinay Kumar Mishra
Name Of Signatory Affirmations
Vinay Kumar Mishra
Name Of Signatory For Annual Affirmations
Vinay Kumar Mishra
Name Of Signatory For Quartely Affirmations
Vinay Kumar Mishra
Name Of The Company
SENORES PHARMACEUTICALS LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Ahmedabad
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
coms02068
Scrip Code
544319
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Yes
Symbol
SENORES
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Any Guarantee Or Comfort Letter Of KM Ps Or Any Other Entity Controlled By Them
Not Applicable
Type Of Any Guarantee Or Comfort Letter Of Promoter Group Or Any Other Entity Controlled By Them
Not Applicable
Type Of Any Guarantee Or Comfort Letter Of Promoter Or Any Other Entity Controlled By Them
Not Applicable
Type Of Company
Equity
Type Of Security Of KM Ps Or Any Other Entity Controlled By Them
Not Applicable
Type Of Security Of Promoter Group Or Any Other Entity Controlled By Them
Not Applicable
Type Of Security Of Promoter Or Any Other Entity Controlled By Them
Not Applicable
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
Yes

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionSpecial Resolution DateInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrSanjay Shaileshbhai Majmudar******00091305Non-Executive - Non Independent DirectorChairperson21-Mar-1963NoActiveNot Applicable10-Feb-202410-Feb-20245051
2MrSwapnil Jatinbhai Shah******05259821Executive DirectorNot ApplicableMD01-Jul-1985NoActiveNot Applicable15-Oct-202115-Oct-20212040
3MrHemanshu Nitinchandra Pandya******10383995Non-Executive - Non Independent DirectorNot Applicable12-Oct-1971NoActiveNot Applicable10-Nov-202310-Nov-20231000
4MrJitendra Babulal Sanghvi******00271995Non-Executive - Non Independent DirectorNot Applicable23-Aug-1979NoActiveNot Applicable23-Nov-202123-Nov-20211000
5MrChetan Bipinchandra Shah******10381971Executive DirectorNot Applicable20-Apr-1966NoActiveNot Applicable10-Nov-202310-Nov-20231000
6MrDeval Rajnikant Shah******00332722Executive DirectorNot Applicable06-Sep-1963NoActiveNot Applicable01-Jan-202001-May-20241000
7MrAshokbhai Vijaysinh Barot******01192300Non-Executive - Non Independent DirectorNot Applicable04-Sep-1966NoActiveNot Applicable15-May-201815-May-20181000
8MrShah Arpit Deepakkumar******07214641Non-Executive - Non Independent DirectorNot Applicable11-Sep-1987NoActiveNot Applicable10-Nov-202310-Nov-20232020
9MrNaresh Bansilal Shah******10384306Non-Executive - Independent DirectorNot Applicable18-Mar-1947NoActiveYes19-Feb-202430-Jan-202430-Jan-202426.011110
10MsManjuladevi Pratul Shroff******00297159Non-Executive - Independent DirectorNot Applicable27-Feb-1964NoActiveNot Applicable30-Jan-202430-Jan-202426.011110
11MrKalpit Rajesh Gandhi******02843308Non-Executive - Independent DirectorNot Applicable03-Feb-1985NoActiveNot Applicable30-Jan-202430-Jan-202426.012131
12MrUdayan Dileep Choksi******02222020Non-Executive - Independent DirectorNot Applicable14-Jan-1976NoActiveNot Applicable08-Mar-202408-Mar-202424.234423

Committee Disclosures

Entry CompComit122
Date of Appointment
12-Jun-2024
Entry CompComit123
Date of Appointment
12-Jun-2024
Entry CompComit124
Date of Appointment
12-Jun-2024
Entry CompComit14
Date of Appointment
09-Apr-2024
Entry CompComit15
Date of Appointment
09-Apr-2024
Entry CompComit16
Date of Appointment
09-Apr-2024
Entry CompComit17
Date of Appointment
09-Apr-2024
Entry CompComit41
Date of Appointment
09-Apr-2024
Entry CompComit42
Date of Appointment
09-Apr-2024
Entry CompComit43
Date of Appointment
09-Apr-2024
Entry CompComit68
Date of Appointment
09-Apr-2024
Entry CompComit69
Date of Appointment
09-Apr-2024
Entry CompComit70
Date of Appointment
09-Apr-2024
Entry CompComit71
Date of Appointment
09-Apr-2024
Entry CompComit95
Date of Appointment
09-Apr-2024
Entry CompComit96
Date of Appointment
09-Apr-2024
Entry CompComit97
Date of Appointment
09-Apr-2024
Entry CompComit98
Date of Appointment
09-Apr-2024
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://senorespharma.com/committees/
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
02843308
Member Name
Kalpit Rajesh Gandhi
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
02222020
Member Name
Udayan Dileep Choksi
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
10384306
Member Name
Naresh Bansilal Shah
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
05259821
Member Name
Swapnil Jatinbhai Shah
Position
Executive Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
00297159
Member Name
Manjuladevi Pratul Shroff
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
05259821
Member Name
Swapnil Jatinbhai Shah
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
01192300
Member Name
Ashokbhai Vijaysinh Barot
Position
Non-Executive - Non Independent Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
02222020
Member Name
Udayan Dileep Choksi
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
02843308
Member Name
Kalpit Rajesh Gandhi
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00091305
Member Name
Sanjay Shaileshbhai Majmudar
Position
Non-Executive - Non Independent Director

Risk Management Committee

Additional Position
Chairperson
Director DIN
10381971
Member Name
Chetan Bipinchandra Shah
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00091305
Member Name
Sanjay Shaileshbhai Majmudar
Position
Non-Executive - Non Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
05259821
Member Name
Swapnil Jatinbhai Shah
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
02222020
Member Name
Udayan Dileep Choksi
Position
Non-Executive - Independent Director

Risk Management Committee

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00091305
Member Name
Sanjay Shaileshbhai Majmudar
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
02843308
Member Name
Kalpit Rajesh Gandhi
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00297159
Member Name
Manjuladevi Pratul Shroff
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
05259821
Member Name
Swapnil Jatinbhai Shah
Position
Executive Director
Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
06-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
11
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
07-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
61
Number Of Directors Present In Meeting Of Board Of Directors
12
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
20-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
12
Number Of Directors Present In Meeting Of Board Of Directors
11
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingBOD4
Dates Of Meeting If Any In The Relevant Quarter
28-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
66
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
06-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
20-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
74
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
28-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
66
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
05-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
19-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
74
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
19-Jan-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://senorespharma.com/investor-grievance/
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://senorespharma.com/investor-grievance/
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Entry D_AcquisitionShares1
Percentage Of Shares Or Voting Rights Acquired During The Quarter
0.75
Entry I_AcquisitionShares_PY1
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0
Entry I_AcquisitionShares1
Date Of Acquisition
16-Jan-2026
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
Apnar Pharma Private Limited
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0.75
Entry MainD
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
Yes
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
No change in the status
Date of Initiation
28-Sep-2019
Opposing Party
Income Tax Department
Status (Previous Disclosure)
Demand raised as per regular assessment for AY 18-19. Writ petition filed with High Court against the assessment order passed. High court has issued stay order.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
No change in the status
Date of Initiation
27-Jun-2022
Opposing Party
Income Tax Department
Status (Previous Disclosure)
Assessment Completed on 30.12.2022 for AY 2021-22 and appeal filed with CIT(A) which is pending for adjudication.
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
Demand order confirming the tax demand of Rs. 24,84,929/- and Penalty of Rs. 24,84,429/-was received by the Company on December 26, 2025. Further,based on merits the Company has filed an appeal before GST Commissioner (Appeals).
Date of Initiation
26-Jan-2024
Opposing Party
Office of the Commissioner Central GST, Audit, Ahmedabad
Status (Previous Disclosure)
Intimation of tax ascertained as being payable u/s 74(5) of CGST Act, 2017 on revenue para 6, 7 and 8 of FAR No. GST -46/2024-25 dated 31.05.24
Entry MainD
Any Other Information For Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Explanatory Text Block
Sr.No.1 and 2, pertains to one of our Material Subsidiaries- Ratnatris Pharmaceuticals Private Limited.
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
Not Applicable
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No